Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-04-21 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
第八届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 9th meeting of the 8th Board of Directors of Ningbo New Zhisheng Biotechnology Co., Ltd. It includes voting results on various agenda items such as approval of the 2023 Annual Report, Board Work Report, General Manager Work Report, Independent Directors' Reports, Financial Statements, Audit Reports, and other related reports. The document references multiple reports and announcements that are disclosed on the Beijing Stock Exchange information platform but does not contain the full reports themselves. The document is a formal board meeting resolution announcement, detailing the approval of reports and proposals, and the submission of some items to the shareholders' meeting for further approval. It is not the annual report itself, nor a financial statement or audit report, but a board/management information announcement about board meeting decisions and approvals. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (4953 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Confidence is high due to the clear nature of the document as a board meeting resolution announcement.
2024-04-21 Chinese
董事会关于独立董事独立性自查情况的专项报告
Regulatory Filings Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of independent directors, referencing regulatory requirements from the China Securities Regulatory Commission and Beijing Stock Exchange guidelines. It details the independence criteria and confirms compliance. The document is not a full annual report, audit report, or financial statement, nor is it an announcement of voting results or a proxy statement. It is a regulatory compliance report related to governance and director independence. Given the nature and content, it fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not fit other specific categories.
2024-04-21 Chinese
关于使用闲置自有资金购买理财产品的的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the use of idle funds to purchase financial products. It details the purpose, amount, decision-making process, risk analysis, and impact on the company. It is a corporate announcement about financing activities, specifically about investing idle funds in low-risk financial products. The document is not a financial report, earnings release, or regulatory filing but an update on capital use and financing activities. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short (1485 characters), and it is not merely announcing a report publication but providing substantive information about the financing decision.
2024-04-21 Chinese
中信证券股份有限公司关于宁波新芝生物科技股份有限公司使用部分闲置募集资金进行现金管理的的核查意见
Regulatory Filings Classification · 85% confidence The document is a detailed sponsor (‘保荐机构’) verification opinion (‘核查意见’) on the use of idle IPO proceeds for cash management by a Beijing Stock Exchange–listed company. It does not contain financial statements or earnings metrics, nor is it a report such as an annual/interim report, proxy statement, audit, or investor presentation. Rather, it is a compliance filing under exchange listing rules. This matches the fallback category for miscellaneous regulatory disclosures.
2024-04-21 Chinese
关于召开 2023 年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2023 Annual General Meeting (AGM) of Ningbo Scientz Biotechnology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed, and references to other reports and announcements available on the Beijing Stock Exchange information disclosure platform. The document does not contain the actual annual report or financial statements but rather informs shareholders about the AGM and the related procedures. The document length is 3803 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-21 Chinese
独立董事2023年度述职报告（毛磊）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2023 Annual Work Report" for Ningbo New Zhi Biotechnology Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions expressed on various company matters, participation in committees, and communication with minority shareholders. The content focuses on the director's duties, meeting participation, and oversight activities during the year 2023. There are no financial statements, audit opinions, or earnings data presented. The document is a report on the independent director's activities and responsibilities rather than a financial report or announcement. This fits best under Board/Management Information (MANG), which covers announcements related to company board or senior management activities and reports.
2024-04-21 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.